ACOSOG Z1041 (Alliance): Definitive analysis of randomized neoadjuvant trial comparing FEC followed by paclitaxel plus trastuzumab (FEC → P+T) with paclitaxel plus trastuzumab followed by FEC plus trastuzumab (P+T → FEC+T) in HER2+ operable breast cancer.
Aman Buzdar
No relevant relationships to disclose
Vera J. Suman
No relevant relationships to disclose
Funda Meric-Bernstam
No relevant relationships to disclose
A. Marilyn Leitch
No relevant relationships to disclose
Matthew James Ellis
No relevant relationships to disclose
Judy Caroline Boughey
No relevant relationships to disclose
Gary Walter Unzeitig
No relevant relationships to disclose
Melanie Royce
No relevant relationships to disclose
Kelly Hunt
No relevant relationships to disclose